RALLYE SA (RAL.PA)

FR0000060618 - Common Stock

0.0441  +0 (+2.56%)

Fundamental Rating

2

Overall RAL gets a fundamental rating of 2 out of 10. We evaluated RAL against 26 industry peers in the Consumer Staples Distribution & Retail industry. RAL may be in some trouble as it scores bad on both profitability and health. RAL has a expensive valuation and it also scores bad on growth.



Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year RAL has reported negative net income.
RAL had a positive operating cash flow in the past year.
RAL had negative earnings in each of the past 5 years.
Each year in the past 5 years RAL had a positive operating cash flow.

1.2 Ratios

RAL has a Return On Assets of -11.26%. This is amonst the worse of the industry: RAL underperforms 82.76% of its industry peers.
The Average Return On Invested Capital over the past 3 years for RAL is significantly below the industry average of 9.15%.
The last Return On Invested Capital (%ROIC%%) for RAL is well below the 3 year average (3.44%), which needs to be investigated, but indicates that RAL had better years and this may not be a problem.
Industry RankSector Rank
ROA -11.26%
ROE N/A
ROIC N/A
ROA(3y)-0.87%
ROA(5y)-1.16%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.44%
ROIC(5y)3.37%

1.3 Margins

RAL has a Operating Margin of 4.83%. This is amongst the best in the industry. RAL outperforms 93.10% of its industry peers.
In the last couple of years the Operating Margin of RAL has grown nicely.
RAL's Gross Margin of 7.87% is on the low side compared to the rest of the industry. RAL is outperformed by 89.66% of its industry peers.
In the last couple of years the Gross Margin of RAL has grown nicely.
Industry RankSector Rank
OM 4.83%
PM (TTM) N/A
GM 7.87%
OM growth 3Y9.77%
OM growth 5Y2.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.87%
GM growth 5Y1.82%

More info and screens

1

2. Health

2.1 Basic Checks

RAL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
RAL has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, RAL has a worse debt to assets ratio.

2.2 Solvency

RAL has an Altman-Z score of 0.63. This is a bad value and indicates that RAL is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.63, RAL is not doing good in the industry: 86.21% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.63
ROIC/WACCN/A
WACC3.68%

2.3 Liquidity

A Current Ratio of 0.92 indicates that RAL may have some problems paying its short term obligations.
RAL has a Current ratio of 0.92. This is comparable to the rest of the industry: RAL outperforms 58.62% of its industry peers.
RAL has a Quick Ratio of 0.92. This is a bad value and indicates that RAL is not financially healthy enough and could expect problems in meeting its short term obligations.
RAL's Quick ratio of 0.92 is amongst the best of the industry. RAL outperforms 86.21% of its industry peers.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.92

More info and screens

2

3. Growth

3.1 Past

RAL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -824.80%.
Looking at the last year, RAL shows a quite strong growth in Revenue. The Revenue has grown by 9.33% in the last year.
The Revenue has been decreasing by -2.63% on average over the past years.
EPS 1Y (TTM)-824.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3989.22%
Revenue 1Y (TTM)9.33%
Revenue growth 3Y-1.25%
Revenue growth 5Y-2.63%
Sales Q2Q%0%

3.2 Future

The Earnings Per Share is expected to decrease by -47.66% on average over the next years. This is quite bad
The Revenue is expected to grow by 7.56% on average over the next years.
EPS Next Y-198.48%
EPS Next 2Y-76.24%
EPS Next 3Y-47.66%
EPS Next 5YN/A
Revenue Next Year10.65%
Revenue Next 2Y8.28%
Revenue Next 3Y7.56%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

RAL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year RAL is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than RAL, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 1.41

4.3 Compensation for Growth

RAL's earnings are expected to decrease with -47.66% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-76.24%
EPS Next 3Y-47.66%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RAL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RALLYE SA

EPA:RAL (4/22/2024, 7:00:00 PM)

0.0441

+0 (+2.56%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)03-14 2024-03-14/amc
Earnings (Next)07-25 2024-07-25
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.33M
Analysts42.86
Price Target0.1 (126.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)-8.41%
DP-0.33%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.92%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0
P/FCF N/A
P/OCF 0.01
P/B N/A
P/tB N/A
EV/EBITDA 1.41
EPS(TTM)-45.5
EYN/A
EPS(NY)-0.74
Fwd EYN/A
FCF(TTM)-28
FCFYN/A
OCF(TTM)3.19
OCFY7240.79%
SpS337.85
BVpS-58.42
TBVpS-58.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.26%
ROE N/A
ROCE -44.35%
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 4.83%
PM (TTM) N/A
GM 7.87%
FCFM N/A
ROA(3y)-0.87%
ROA(5y)-1.16%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)3.44%
ROIC(5y)3.37%
ROICexc(3y)3.95%
ROICexc(5y)3.96%
ROICexgc(3y)9.21%
ROICexgc(5y)9.53%
ROCE(3y)4.68%
ROCE(5y)4.59%
ROICexcg growth 3Y2.62%
ROICexcg growth 5Y-2.33%
ROICexc growth 3Y7.9%
ROICexc growth 5Y2.55%
OM growth 3Y9.77%
OM growth 5Y2.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.87%
GM growth 5Y1.82%
F-Score5
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 7.49%
Profit Quality N/A
Current Ratio 0.92
Quick Ratio 0.92
Altman-Z 0.63
F-Score5
WACC3.68%
ROIC/WACCN/A
Cap/Depr(3y)91.16%
Cap/Depr(5y)89.32%
Cap/Sales(3y)3.77%
Cap/Sales(5y)3.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-824.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3989.22%
EPS Next Y-198.48%
EPS Next 2Y-76.24%
EPS Next 3Y-47.66%
EPS Next 5YN/A
Revenue 1Y (TTM)9.33%
Revenue growth 3Y-1.25%
Revenue growth 5Y-2.63%
Sales Q2Q%0%
Revenue Next Year10.65%
Revenue Next 2Y8.28%
Revenue Next 3Y7.56%
Revenue Next 5YN/A
EBIT growth 1Y133.51%
EBIT growth 3Y8.39%
EBIT growth 5Y0.07%
EBIT Next Year121.31%
EBIT Next 3Y35.24%
EBIT Next 5YN/A
FCF growth 1Y-248.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-91.45%
OCF growth 3Y3.06%
OCF growth 5Y3.77%